What is Transplant Diagnostics? A Brief Sneak-Peak and Insights – Arizton

13 October 2020

Transplant historically has been associated with a heart, liver, kidney, or lung transplant and most people have heard about this once in their lifetime. However, new-age healthcare is opening the door to stem cell, bone marrow, and tissue transplantations with higher rate of successes and accuracies. These advances help healthcare providers offer valued-based care to patients for various acute and chronic diseases.

Did you know, the world’s first millionth blood stem cell transplant was performed in 2012 and more than 70,000 stem cell transplants were performed in 2013 globally?

Without the advancement in the transplantations and focus on using innovative transplant diagnostics, these modern medicine marvels would be impossible to achieve. Further, investments in R&D for improve these transplant diagnostics helps doctors save millions of lives across the global annually.

Read: Transplant Diagnostics Market Global Outlook and Forecast 2020-2025

The Role of Diagnostics in Transplantations

Why is it important? Two words – the potential risks and complications that are related to pre- and post-transplantations. Without it, patients with weakened immunity run the risk of acquiring HAIs or worse can start rejecting the transplantation thereby, increasing the risk of losing the life of the patient. This procedure is sort of a harmonious collaboration between healthcare professionals and laboratory experts who are focused on ensuring improved patient outcomes.

Reliable in-vitro diagnostics (IVD) tests play a pivotal role in transplantation safety. A variety of tests can be performed pre- and post-transplantation.

Such tests are majorly classified as:

  • Pre-transplantation tests: The test includes serological or non-molecular tests in order to characterize donors, organs and tissues, and recipients for the presence of active or past infections
  • Post-transplantation tests: The test commonly include molecular tests such as nucleic acid tests (NAT) to test and monitor recipients during and after the treatment

Therefore, diagnostic tests in organ, cell, and tissue transplantation to mitigate potential risks of various transplant-transmitted complications require a wide variety of advanced laboratory instruments, accessories, and application software for better safety and efficacy.

Furthermore, manufacturers such as Thermo Fisher Scientific, F. Hoffmann-La Roche, bioMérieux, Bio-Rad Laboratories, QIAGEN, and Immucor are continuously focusing on new product development as well as strategic acquisitions in order to expand themselves and remain competitive in the market.

Read: Infectious Disease Diagnostics Market Global Outlook and Forecast 2020-2025

Frequently Asked Questions about the Transplant Diagnostics Market include:

Q) What is the market size of transplant diagnostics?

A) The global transplant diagnostics market size is expected to reach revenues of over $1.7 billion by 2025.

Q) What is the market share of transplant diagnostics?

A) The transplant diagnostics market is growing at a steady rate, and the trend is expected to continue during the forecast period.

Q) What is the market growth of transplant diagnostics?

A) The transplant diagnostics market is projected to grow at a CAGR of over 6% during 2019-2025.

Q) What are the market insights?

A) A diverse range of factors will continue influencing the growth of the global transplant diagnostics market and the demand for new and innovative transplant diagnostics instruments/analyzers and software will continue to increase.

Q) Who are the top vendors in the market?

A) The top vendors in the transplant diagnostics market include Thermo Fisher Scientific, Hoffmann-La Roche, bioMérieux, Bio-Rad Laboratories, QIAGEN, and Immucor

Q) What is the market segmentation?

A) The transplant diagnostics market segmentation includes product, application, technology, transplantation type, end-user, and geography.

Q) What are the opportunities available in the transplant market?

A) Some of the opportunities in the transplant diagnostics market include the emergence of cfDNA, expansion and demand from various emerging economies, and focus on identifying novel biomarkers for minimizing transplantation rejection.

Q) What are the major challenges faced by the players in the transplant market?

A) The major challenges for players in the market are the increasing gap between number of organ donors & recipients, ethical challenges in organ procurement and treatment, and high costs associated with transplant diagnostics.

Oct 16, 2020

Is IoT & Smart Lighting the Next Big Thing in the Work Light Market?

The global work light market plays an important role for businesses over the next few years. The glo...

Oct 16, 2020

The Attack of Coronavirus on Toys Market: Good or Bad? – Arizton

The COVID-19 outbreak has completely disrupted the supply chain in the global toys market growth. Q...

Oct 15, 2020

Sharp Rise in Demand for Medical Mask due to the COVID-19 Pandemic

Medical masks are essential during the COVID-19 outbreak. Medical face masks can slow the spread of ...